UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The hunt for nutritional and pharmacological modulators of paraoxonase

Arteriosclerosis, thrombosis, and vascular biology, 2002-08, Vol.22 (8), p.1248-1250

2002

Volltextzugriff (PDF)

Paraoxonase and atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2001-04, Vol.21 (4), p.473-480

2001

Volltextzugriff (PDF)

Lack of Protection against Oxidative Modification of LDL by Avian HDL

Biochemical and biophysical research communications, 1998-06, Vol.247 (2), p.443-446

1998

Volltextzugriff (PDF)

The separation of sheep and human serum "A"-esterase activity into the lipoprotein fraction by ultracentrifugation

Comparative biochemistry and physiology. B, Comparative biochemistry, 1985, Vol.82 (4), p.675-677

1985

Volltextzugriff (PDF)

Multicentre interlaboratory study of lipoprotein (A) (L p(A) assay methods

Atherosclerosis, 1993-01, Vol.98 (1), p.119-119

Mackness, M.I.

1993

Volltextzugriff (PDF)

Paraoxonase (PON1) & coronary heart disease (CHD)

Atherosclerosis, 2000-07, Vol.151 (1), p.57-57

2000

Volltextzugriff (PDF)

HDL prevents the formation of aldehyde adducts on apo-B during the oxidation of LDL

Atherosclerosis, 2000-07, Vol.151 (1), p.260-260

2000

Volltextzugriff (PDF)

4.P.69 Serum platelet activating factor-acetylhydrolase (PAF-AH) activity in diabetes

Atherosclerosis, 1997-10, Vol.134 (1-2), p.310-310

1997

Volltextzugriff (PDF)

9. Role of HDL in preventing atherogenic modification of LDL

Atherosclerosis, 1999, Vol.146, p.S13-S13

1999

Volltextzugriff (PDF)

The effect of atorvastatin on serum lipide, lipoproteins and NMR-spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Atherosclerosis, 2003, Vol.167 (2)

2003

Volltextzugriff (PDF)

3.P.81 Immunolocalisation of paraoxonase with clusterin and apolipoprotein A1 in the human artery wall

Atherosclerosis, 1997-10, Vol.134 (1-2), p.215-215

1997

Volltextzugriff (PDF)

Paraoxonase: another factor in NIDDM cardiovascular disease

The Lancet (British edition), 1995-09, Vol.346 (8979), p.856-856

1995

Volltextzugriff (PDF)

Treatment of mixed hyperlipidaemia using a combination of omega-3 fatty acids and HMG CoA reductase inhibitor

European heart journal supplements, 2001-06, Vol.3 (suppl-D), p.D53-D58

2001

Volltextzugriff (PDF)

The effect of insulin, glucagon and oleic acid on the particle size and composition of apolipoprotein B-containing lipoproteins secreted by HEP G2 cells

Atherosclerosis, 1995-06, Vol.115, p.S24-S24

1995

Volltextzugriff (PDF)

Paraoxonase: an enzyme of the high density lipoprotein (HDL) with decreased activity in diabetes mellitus and heterozygous familial hypercholesterolaemia (FH)

Atherosclerosis, 1990-11, Vol.85 (1), p.94-94

1990

Volltextzugriff (PDF)

Protection against accumulation of peroxides in LDL by HDL and its associated enzyme, paraoxonase

Atherosclerosis, 1994-09, Vol.109 (1), p.55-55

1994

Volltextzugriff (PDF)

Hydrolysis of platelet-activating factor by purified HDL-associated paraoxonase

Atherosclerosis, 1994-09, Vol.109 (1), p.233-233

1994

Volltextzugriff (PDF)

The effects of saturated fatty acids on apolipoprotein B secretion by human hepatoma (Hep G2) cells

Atherosclerosis, 1993-11, Vol.103 (2), p.298-298

1993

Volltextzugriff (PDF)

Susceptibility of low and high density lipoproteins from subjects with diabetes to in vitro oxidative modification

Atherosclerosis, 1995-06, Vol.115, p.S23-S23

1995

Volltextzugriff (PDF)

Serum paraoxonase activity in Type 1 and Type 2 diabetes

Atherosclerosis, 1994-09, Vol.109 (1), p.247-247

1994

Volltextzugriff (PDF)

Transfer of cholesteryl esters from HDL to VLDL and LDL (CET) is increased in patients with type 2 diabetes mellitus (DM)

Atherosclerosis, 1994-09, Vol.109 (1), p.236-236

1994

Volltextzugriff (PDF)

Susceptibility of LDL and HDL from patients with diabetes mellitus to in vitro oxidative modification

Atherosclerosis, 1994-09, Vol.109 (1), p.55-55

1994

Volltextzugriff (PDF)

Multiple forms of sheep serum A-esterase activity associated with the high-density lipoprotein

Biochemical journal, 1988-03, Vol.250 (2), p.539-545

1988

Volltextzugriff (PDF)

Serum lipids & apolipoproteins in South Asians living in the UK and their siblings in India

Atherosclerosis, 1993-11, Vol.103 (2), p.296-296

1993

Volltextzugriff (PDF)

Effect of oral supplementation with micronutrient antioxidants on trans fatty acid content of lipoproteins in healthy humans

Biochemical Society transactions, 1996-05, Vol.24 (2), p.191S-191S

1996

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The hunt for nutritional and pharmacological modulators of paraoxonase

Paraoxonase and atherosclerosis

Lack of Protection against Oxidative Modification of LDL by Avian HDL

The separation of sheep and human serum "A"-esterase activity into the lipoprotein fraction by ultracentrifugation

Multicentre interlaboratory study of lipoprotein (A) (L p(A) assay methods

Paraoxonase (PON1) & coronary heart disease (CHD)

HDL prevents the formation of aldehyde adducts on apo-B during the oxidation of LDL

4.P.69 Serum platelet activating factor-acetylhydrolase (PAF-AH) activity in diabetes

9. Role of HDL in preventing atherogenic modification of LDL

The effect of atorvastatin on serum lipide, lipoproteins and NMR-spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

3.P.81 Immunolocalisation of paraoxonase with clusterin and apolipoprotein A1 in the human artery wall

Paraoxonase: another factor in NIDDM cardiovascular disease

Treatment of mixed hyperlipidaemia using a combination of omega-3 fatty acids and HMG CoA reductase inhibitor

The effect of insulin, glucagon and oleic acid on the particle size and composition of apolipoprotein B-containing lipoproteins secreted by HEP G2 cells

Paraoxonase: an enzyme of the high density lipoprotein (HDL) with decreased activity in diabetes mellitus and heterozygous familial hypercholesterolaemia (FH)

Protection against accumulation of peroxides in LDL by HDL and its associated enzyme, paraoxonase

Hydrolysis of platelet-activating factor by purified HDL-associated paraoxonase

The effects of saturated fatty acids on apolipoprotein B secretion by human hepatoma (Hep G2) cells

Susceptibility of low and high density lipoproteins from subjects with diabetes to in vitro oxidative modification

Serum paraoxonase activity in Type 1 and Type 2 diabetes

Transfer of cholesteryl esters from HDL to VLDL and LDL (CET) is increased in patients with type 2 diabetes mellitus (DM)

Susceptibility of LDL and HDL from patients with diabetes mellitus to in vitro oxidative modification

Multiple forms of sheep serum A-esterase activity associated with the high-density lipoprotein

Serum lipids & apolipoproteins in South Asians living in the UK and their siblings in India

Effect of oral supplementation with micronutrient antioxidants on trans fatty acid content of lipoproteins in healthy humans

Aktive Filter

Suchergebnisse filtern